Kevin Gene Peters

Person

Loveland, OH, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions, formulations and methods for treating ocular diseases
- Patent number 12,152,023
- Issue date Nov 26, 2024
- EYEPOINT PHARMACEUTICALS, INC.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating an ocular condition by administering a humanized...
- Patent number 12,145,986
- Issue date Nov 19, 2024
- EYEPOINT PHARMACEUTICALS, INC.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tie-2 activators targeting the Schlemm's canal
- Patent number 12,064,420
- Issue date Aug 20, 2024
- EYEPOINT PHARMACEUTICALS, INC.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating vascular leak syndrome and cancer
- Patent number 12,043,664
- Issue date Jul 23, 2024
- EYEPOINT PHARMACEUTICALS, INC.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating ocular conditions by administering an antibody t...
- Patent number 11,873,334
- Issue date Jan 16, 2024
- EYEPOINT PHARMACEUTICALS, INC.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that bind human protein tyrosine phosphatase beta (HPTPb...
- Patent number 11,814,425
- Issue date Nov 14, 2023
- Eye Point Pharmaceuticals, Inc.
- Rocco Jamie Rotello
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating intraocular pressure with activators of Tie-2
- Patent number 11,666,558
- Issue date Jun 6, 2023
- EYEPOINT PHARMACEUTICALS, INC.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulations of Tie-2 activators and methods of use thereof
- Patent number 11,413,242
- Issue date Aug 16, 2022
- EYEPOINT PHARMACEUTICALS, INC.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tie-2 activators targeting the Schlemm's canal
- Patent number 11,253,502
- Issue date Feb 22, 2022
- EYEPOINT PHARMACEUTICALS, INC.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized monoclonal antibodies that target VE-PTP (HPTP-beta)
- Patent number 11,180,551
- Issue date Nov 23, 2021
- EYEPOINT PHARMACEUTICALS, INC.
- Kevin Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized monoclonal antibodies that target VE-PTP (HPTP-β)
- Patent number 11,136,389
- Issue date Oct 5, 2021
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating intraocular pressure with activators of Tie-2
- Patent number 10,952,992
- Issue date Mar 23, 2021
- Aerpio Pharmaceuticals, Inc.
- Kevin Gene Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multispecific antibodies that target HPTP-β (VE-PTP) and VEGF
- Patent number 10,894,824
- Issue date Jan 19, 2021
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HPTP-Beta inhibitors
- Patent number 10,858,354
- Issue date Dec 8, 2020
- Aerpio Pharmaceuticals, Inc.
- John Janusz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating vascular leak syndrome and cancer
- Patent number 10,815,300
- Issue date Oct 27, 2020
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized monoclonal antibodies that target protein tyrosine phosph...
- Patent number 10,604,569
- Issue date Mar 31, 2020
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating ocular conditions by administering humanized mo...
- Patent number 10,597,452
- Issue date Mar 24, 2020
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of ocular disease
- Patent number 10,329,357
- Issue date Jun 25, 2019
- Aerpio Therapeutics, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that target human protein tyrosine phosphatase-beta (HPT...
- Patent number 10,253,094
- Issue date Apr 9, 2019
- Aerpio Therapeutics, Inc.
- Kevin Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating ocular diseases
- Patent number 10,220,048
- Issue date Mar 5, 2019
- Aerpio Therapeutics, Inc.
- Kevin Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating vascular leak syndrome and cancer
- Patent number 10,150,811
- Issue date Dec 11, 2018
- Aerpio Therapeutics, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HPTP-β inhibitors
- Patent number 9,994,560
- Issue date Jun 12, 2018
- Aerpio Therapeutics, Inc.
- John Janusz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions, and methods for preventing metastasis of c...
- Patent number 9,949,956
- Issue date Apr 24, 2018
- Aerpio Therapeutics, Inc.
- Robert Shalwitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that bind human protein tyrosine phosphatase beta (HPTPb...
- Patent number 9,926,367
- Issue date Mar 27, 2018
- Aerpio Therapeutics, Inc.
- Rocco Jamie Rotello
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of immunotherapies with activators of Tie-2
- Patent number 9,539,245
- Issue date Jan 10, 2017
- Aerpio Therapeutics, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions, formulations and methods for treating ocular diseases
- Patent number 9,440,963
- Issue date Sep 13, 2016
- Aerpio Therapeutics, Inc.
- Kevin Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds, compositions, and methods for preventing metastasis of c...
- Patent number 9,174,950
- Issue date Nov 3, 2015
- Aerpio Therapeutics, Inc.
- Robert Shalwitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating vascular leak syndrome
- Patent number 9,096,555
- Issue date Aug 4, 2015
- Aerpio Therapeutics, Inc.
- Robert Shalwitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of ocular disease
- Patent number 8,999,325
- Issue date Apr 7, 2015
- Aerpio Therapeutics, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds, compositions, and methods for preventing metastasis of c...
- Patent number 8,883,832
- Issue date Nov 11, 2014
- Aerpio Therapeutics Inc.
- Robert Shalwitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF TREATING ACUTE RESPIRATORY DISTRESS SYNDROME WITH ACTIVA...
- Publication number 20240299367
- Publication date Sep 12, 2024
- Kevin PETERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODIES THAT TARGET HPTP-BETA (VE-PTP) AND VEGF
- Publication number 20240174740
- Publication date May 30, 2024
- EyePoint Pharmaceuticals, Inc.
- Kevin PETERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING INTRAOCULAR PRESSURE WITH ACTIVATORS OF TIE-2
- Publication number 20230398100
- Publication date Dec 14, 2023
- EyePoint Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF TIE-2 ACTIVATORS AND METHODS OF USE THEREOF
- Publication number 20230139250
- Publication date May 4, 2023
- EyePoint Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta)
- Publication number 20230134885
- Publication date May 4, 2023
- EyePoint Pharmaceuticals, Inc.
- Kevin PETERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES
- Publication number 20220274976
- Publication date Sep 1, 2022
- EyePoint Pharmaceuticals, Inc.
- Kevin PETERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TIE-2 ACTIVATORS TARGETING THE SCHLEMM'S CANAL
- Publication number 20220211675
- Publication date Jul 7, 2022
- EyePoint Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZAT...
- Publication number 20220016086
- Publication date Jan 20, 2022
- Aerpio Pharmaceuticals, Inc.
- Kevin Gene Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING INTRAOCULAR PRESSURE WITH ACTIVATORS OF TIE-2
- Publication number 20210386713
- Publication date Dec 16, 2021
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combinations of Tie-2 Activators and Prostaglandins and Uses Thereof
- Publication number 20210212998
- Publication date Jul 15, 2021
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODIES THAT TARGET HPTP-B (VE-PTP) AND VEGF
- Publication number 20210171618
- Publication date Jun 10, 2021
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HPTP-BETA INHIBITORS
- Publication number 20210130341
- Publication date May 6, 2021
- Aerpio Pharmaceuticals, Inc.
- John Janusz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATING VASCULAR LEAK SYNDROME AND CANCER
- Publication number 20210095017
- Publication date Apr 1, 2021
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPb...
- Publication number 20200407430
- Publication date Dec 31, 2020
- Aerpio Pharmaceuticals, Inc.
- Rocco Jamie Rotello
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF TIE-2 ACTIVATORS AND METHODS OF USE THEREOF
- Publication number 20200397697
- Publication date Dec 24, 2020
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES
- Publication number 20200361926
- Publication date Nov 19, 2020
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING HYPERTENSION WITH ACTIVATORS OF TIE-2
- Publication number 20200352914
- Publication date Nov 12, 2020
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TIE-2 ACTIVATORS TARGETING THE SCHLEMM'S CANAL
- Publication number 20200338048
- Publication date Oct 29, 2020
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING VASCULAR LEAK SYNDROME
- Publication number 20200277267
- Publication date Sep 3, 2020
- Aerpio Pharmaceuticals, Inc.
- Robert Shalwitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta)
- Publication number 20200270342
- Publication date Aug 27, 2020
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta)
- Publication number 20200239567
- Publication date Jul 30, 2020
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF OCULAR DISEASE
- Publication number 20200231703
- Publication date Jul 23, 2020
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING VASCULAR LEAK SYNDROME
- Publication number 20200207730
- Publication date Jul 2, 2020
- Aerpio Pharmaceuticals, Inc.
- Robert Shalwitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
- Publication number 20200108080
- Publication date Apr 9, 2020
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODIES THAT TARGET HPTP-B (VE-PTP) AND VEGF
- Publication number 20200095309
- Publication date Mar 26, 2020
- Aerpio Pharmaceuticals, Inc.
- Kevin Peters
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZAT...
- Publication number 20200009115
- Publication date Jan 9, 2020
- Aerpio Pharmaceuticals, Inc.
- Kevin Gene PETERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF OCULAR DISEASE
- Publication number 20200010565
- Publication date Jan 9, 2020
- AERPIO THERAPEUTICS, INC.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING DIABETIC NEPHROPATHY USING HPTPB INHIBITORS
- Publication number 20190262321
- Publication date Aug 29, 2019
- AERPIO THERAPEUTICS, INC.
- Kevin PETERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
- Publication number 20190231799
- Publication date Aug 1, 2019
- Aerpio Therapeutics, Inc.
- Kevin Peters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING VASCULAR LEAK SYNDROME AND CANCER
- Publication number 20190177409
- Publication date Jun 13, 2019
- AERPIO THERAPEUTICS, INC.
- Kevin Peters
- C07 - ORGANIC CHEMISTRY

Kevin Gene Peters

Person

Patents Grantslast 30 patents

Compositions, formulations and methods for treating ocular diseases

Method of treating an ocular condition by administering a humanized...

Tie-2 activators targeting the Schlemm's canal

Methods for treating vascular leak syndrome and cancer

Method of treating ocular conditions by administering an antibody t...

Antibodies that bind human protein tyrosine phosphatase beta (HPTPb...

Methods of treating intraocular pressure with activators of Tie-2

Formulations of Tie-2 activators and methods of use thereof

Tie-2 activators targeting the Schlemm's canal

Humanized monoclonal antibodies that target VE-PTP (HPTP-beta)

Humanized monoclonal antibodies that target VE-PTP (HPTP-β)

Methods of treating intraocular pressure with activators of Tie-2

Multispecific antibodies that target HPTP-β (VE-PTP) and VEGF

HPTP-Beta inhibitors

Methods for treating vascular leak syndrome and cancer

Humanized monoclonal antibodies that target protein tyrosine phosph...

Methods of treating ocular conditions by administering humanized mo...

Treatment of ocular disease

Antibodies that target human protein tyrosine phosphatase-beta (HPT...

Compositions and methods for treating ocular diseases

Methods for treating vascular leak syndrome and cancer

HPTP-β inhibitors

Compounds, compositions, and methods for preventing metastasis of c...

Antibodies that bind human protein tyrosine phosphatase beta (HPTPb...

Combination of immunotherapies with activators of Tie-2

Compositions, formulations and methods for treating ocular diseases

Compounds, compositions, and methods for preventing metastasis of c...

Methods for treating vascular leak syndrome

Treatment of ocular disease

Compounds, compositions, and methods for preventing metastasis of c...

Patents Applicationslast 30 patents

METHODS OF TREATING ACUTE RESPIRATORY DISTRESS SYNDROME WITH ACTIVA...

MULTISPECIFIC ANTIBODIES THAT TARGET HPTP-BETA (VE-PTP) AND VEGF

METHODS OF TREATING INTRAOCULAR PRESSURE WITH ACTIVATORS OF TIE-2

FORMULATIONS OF TIE-2 ACTIVATORS AND METHODS OF USE THEREOF

HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta)

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

TIE-2 ACTIVATORS TARGETING THE SCHLEMM'S CANAL

COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZAT...

METHODS OF TREATING INTRAOCULAR PRESSURE WITH ACTIVATORS OF TIE-2

Combinations of Tie-2 Activators and Prostaglandins and Uses Thereof

MULTISPECIFIC ANTIBODIES THAT TARGET HPTP-B (VE-PTP) AND VEGF

HPTP-BETA INHIBITORS

METHODS FOR TREATING VASCULAR LEAK SYNDROME AND CANCER

ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPb...

FORMULATIONS OF TIE-2 ACTIVATORS AND METHODS OF USE THEREOF

COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES

METHODS OF TREATING HYPERTENSION WITH ACTIVATORS OF TIE-2

TIE-2 ACTIVATORS TARGETING THE SCHLEMM'S CANAL

METHODS FOR TREATING VASCULAR LEAK SYNDROME

HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta)

HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-Beta)

TREATMENT OF OCULAR DISEASE

METHODS FOR TREATING VASCULAR LEAK SYNDROME

COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES

MULTISPECIFIC ANTIBODIES THAT TARGET HPTP-B (VE-PTP) AND VEGF

COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZAT...

TREATMENT OF OCULAR DISEASE

METHODS OF TREATING DIABETIC NEPHROPATHY USING HPTPB INHIBITORS

COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES

METHODS FOR TREATING VASCULAR LEAK SYNDROME AND CANCER